Margaritopoulos George A, Vasarmidi Eirini, Jacob Joseph, Wells Athol U, Antoniou Katerina M
Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Dept of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Interstitial Lung Disease Unit, University Hospital of Heraklion, Heraklion, Greece.
Eur Respir Rev. 2015 Sep;24(137):428-35. doi: 10.1183/16000617.0050-2015.
For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases. In the recent years, attention has also focused on the role of smoking in the development of interstitial lung diseases (ILDs). Indeed, there are three diseases, namely respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia and pulmonary Langerhans cell histiocytosis, that are currently considered aetiologically linked to smoking and a few others which are more likely to develop in smokers. Here, we aim to focus on the most recent findings regarding the role of smoking in the pathogenesis and clinical behaviour of ILDs.
多年来,人们一直都清楚吸烟会导致肺部损伤。慢性阻塞性肺疾病和肺癌一直是两种最常见的与吸烟相关的肺部疾病。近年来,人们也将注意力集中在了吸烟在间质性肺疾病(ILDs)发展过程中的作用上。的确,目前有三种疾病,即呼吸性细支气管炎相关的ILD、脱屑性间质性肺炎和肺朗格汉斯细胞组织细胞增多症,被认为在病因上与吸烟有关,还有其他一些疾病在吸烟者中更易发生。在此,我们旨在聚焦于吸烟在ILDs发病机制和临床行为方面作用的最新研究发现。